Email this article to a friend
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
-
* Corresponding author: Michael Pollak michael.pollak@mcgill.ca
Breast Cancer Research 2005, 7:R570-R579 doi:10.1186/bcr1028